Diamedical Medical Center 2013 Ltd.
- Address
- lock Available on a paid plan
Cardiovascular Diseases
At Diamedical Medical Center 2013 Ltd. in Dimitrovgrad, Bulgaria, clinical research in cardiovascular diseases focuses on conditions such as heart failure, hypertension, and atherosclerotic cardiovascular disease. These studies are designed to test new treatments and assess whether they can lower major heart-related risks and improve outcomes for people with established disease.
- Research on heart failure and related complications
- Studies in hypertension and high cardiovascular risk
- Trials aimed at reducing major adverse cardiovascular events
The site is also involved in studies of cardiovascular disease linked with chronic kidney disease and systemic inflammation, reflecting a broad effort to improve treatment effectiveness across complex heart and vessel disorders.
Nutritional and Metabolic Diseases
The site’s nutritional and metabolic disease research centers on hypertriglyceridemia, severe hypertriglyceridemia, and type 2 diabetes. These trials are mainly evaluating new therapies that may help lower triglyceride levels, support metabolic control, and reduce the risk of future cardiovascular complications.
- Studies in hypertriglyceridemia and severe hypertriglyceridemia
- Research involving type 2 diabetes and related cardiovascular risk
- Trials focused on improving lipid control and long-term safety
Several studies are examining whether new medicines can more effectively reduce fasting triglycerides in people with persistent or severe lipid abnormalities.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
This therapeutic area is represented through studies that explore inherited and early-life disease patterns, with an emphasis on understanding how underlying biological factors may influence later cardiovascular and metabolic health. The research aims to improve detection, risk assessment, and broader disease management.
- Investigation of hereditary disease-related risk connected to chronic cardiometabolic illness
- Research into conditions that may shape long-term cardiovascular outcomes
- Studies supporting better diagnosis and patient stratification
At Diamedical Medical Center 2013 Ltd., this area complements the site’s broader focus on chronic disease research by linking early biological influences with adult heart and metabolic disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 6 by active trials.
lock +5 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Arrowhead Pharmaceuticals Inc.4trials
lock +4 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Diamedical Medical Center 2013 Ltd.
lock Showing 1 of 19 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3 Study to Compare the Efficacy and Safety of KAI-9531 Versus Semaglutide in Participants Living with Obesity Without Diabetes | Kailera Therapeutics Inc. | Phase III | Recruiting | Jun 2026 | — |
IMP list
lock Showing 1 of 14 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues | 4 | Unknown | 2024-11-04 | 2025-12-08 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.